John Conrad Cruz Uy

John Conrad Uy practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

John Conrad Uy's NPI, 1184273609, was assigned on September 6, 2019. John Conrad Uy holds California license 95012718.

John Conrad Uy's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

John Conrad Uy's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. John Conrad Uy is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is UCSF Pediatrics. Dmand AI also links John Conrad Uy to 2 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Conrad Uy practices, 4 sites in all. Vendor and product names are available with a free account.

Acute care is John Conrad Uy's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. John Conrad Uy is licensed in California.

CMS counts 61 Medicare patients who saw John Conrad Uy in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Conrad Uy's median patient age at 71, with 52% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for John Conrad Uy for performance year 2024, reported as part of a group. John Conrad Uy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists John Conrad Uy as offering telehealth.

CMS Open Payments shows 3 general payments to John Conrad Uy from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Pulmonx Corporation paid the most, $193.